Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 1390 Results Clear All
A new documentary follows Jim Dunn’s end-of-life decision to donate his tissues to HIV research.
Institutional News HIV/AIDS Infectious Disease Roan Lab
Scientists at Gladstone show the new method could treat the majority of patients with Charcot-Marie-Tooth disease.
News Release Research (Publication) Neurological Disease Conklin Lab CRISPR/Gene Editing
From fundamental insights to translational advances, here’s how Gladstone researchers moved science forward in 2025.
Gladstone Experts Alzheimer’s Disease Autoimmune Diseases COVID-19 Neurological Disease Genomic Immunology Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab
Among his myriad accomplishments, Rudolf Jaenisch—winner of the 2025 Ogawa-Yamanaka Stem Cell Prize—was the first to demonstrate the potential of induced pluripotent stem cells to treat disease.
Awards Ogawa Stem Cell Prize Profile Regenerative Medicine Stem Cells/iPSCs
Findings of the new study in Nature could streamline scientific discovery and accelerate drug development.
News Release Research (Publication) Marson Lab Genomics
Seth Shipman and his team recently identified seven new retrons from environmental bacteria by sampling soil and water in nature.
Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
The featured scientists include global leaders in gene editing, data science, and immunology.
Awards News Release Corces Lab Doudna Lab Marson Lab Pollard Lab Ye Lab
Innovative Genomics Institute—A team of researchers, including Gladstone Investigator Jennifer Doudna, reveal that viruses have evolved a surprisingly large and diverse set of enzymes specifically designed to destroy immune alarm signals from cells, helping them disable the host’s antiviral defenses.
Gladstone Experts Infectious Disease Doudna Lab
Earth.com—A study by Gladstone Investigator Ken Nakamura helps answer a long-standing debate about Parkinson’s disease: do the cell’s tiny energy factories fail first and spark the disorder, or do they crumble only after brain cells have already begun to die?
Gladstone Experts Parkinson’s Disease Neurological Disease Nakamura Lab
Inside Precision Medicine—A new study by Gladstone Investigator Ken Nakamura has found that a mitochondrial protein, CHCHD2, can drive a sequence of cellular events that lead to the development Parkinson’s disease.
Gladstone Experts Parkinson’s Disease Neurological Disease Nakamura Lab
CRISPR Medicine News—Gladstone Investigator Bruce Conklin showed how manipulating DNA repair responses in neurons after CRISPR editing can direct outcomes and improve editing efficiency.
Gladstone Experts Neurological Disease Conklin Lab CRISPR/Gene Editing
The striking findings of a new study could influence how gene therapies are designed for many genetic diseases.
News Release Research (Publication) Neurological Disease Conklin Lab Doudna Lab CRISPR/Gene Editing
Potrero View—This profile of Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, describes how she became one of the world’s leading scientists in computational genomics, and how her team is using artificial intelligence to decode the fundamental language of life itself.
Gladstone Experts Pollard Lab
A new study from Gladstone Institutes strengthens the links between energy breakdown in cells and the onset of Parkinson’s, potentially illuminating new paths for treatment.
News Release Research (Publication) Parkinson’s Disease Neurological Disease Nakamura Lab
Scientists learn to fine-tune a gene that is centrally involved in regulating the immune system, offering potential clues for future autoimmunity and cancer treatments.
News Release Research (Publication) Autoimmune Diseases Cancer Genomic Immunology Marson Lab
